These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 29326336)

  • 21. Positive and negative transcriptional control by the TAL1 helix-loop-helix protein.
    Hsu HL; Wadman I; Tsan JT; Baer R
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5947-51. PubMed ID: 8016094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TAL1/SCL induces leukemia by inhibiting the transcriptional activity of E47/HEB.
    O'Neil J; Shank J; Cusson N; Murre C; Kelliher M
    Cancer Cell; 2004 Jun; 5(6):587-96. PubMed ID: 15193261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromatin looping defines expression of TAL1, its flanking genes, and regulation in T-ALL.
    Zhou Y; Kurukuti S; Saffrey P; Vukovic M; Michie AM; Strogantsev R; West AG; Vetrie D
    Blood; 2013 Dec; 122(26):4199-209. PubMed ID: 24200685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TAL1 as a master oncogenic transcription factor in T-cell acute lymphoblastic leukemia.
    Sanda T; Leong WZ
    Exp Hematol; 2017 Sep; 53():7-15. PubMed ID: 28652130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FUSE binding protein 1 (FUBP1) expression is upregulated by T-cell acute lymphocytic leukemia protein 1 (TAL1) and required for efficient erythroid differentiation.
    Steiner M; Schneider L; Yillah J; Gerlach K; Kuvardina ON; Meyer A; Maring A; Bonig H; Seifried E; Zörnig M; Lausen J
    PLoS One; 2019; 14(1):e0210515. PubMed ID: 30653565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SIX6 is a TAL1-regulated transcription factor in T-ALL and associated with inferior outcome.
    Laukkanen S; Oksa L; Nikkilä A; Lahnalampi M; Parikka M; Seki M; Takita J; Degerman S; de Bock CE; Heinäniemi M; Lohi O
    Leuk Lymphoma; 2020 Dec; 61(13):3089-3100. PubMed ID: 32835548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FOXP3 can modulate TAL1 transcriptional activity through interaction with LMO2.
    Fleskens V; Mokry M; van der Leun AM; Huppelschoten S; Pals CE; Peeters J; Coenen S; Cardoso BA; Barata JT; van Loosdregt J; Coffer PJ
    Oncogene; 2016 Aug; 35(31):4141-8. PubMed ID: 26686090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. mSin3A regulates murine erythroleukemia cell differentiation through association with the TAL1 (or SCL) transcription factor.
    Huang S; Brandt SJ
    Mol Cell Biol; 2000 Mar; 20(6):2248-59. PubMed ID: 10688671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biallelic transcriptional activation of oncogenic transcription factors in T-cell acute lymphoblastic leukemia.
    Ferrando AA; Herblot S; Palomero T; Hansen M; Hoang T; Fox EA; Look AT
    Blood; 2004 Mar; 103(5):1909-11. PubMed ID: 14604958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tal1/SCL binding to pericentromeric DNA represses transcription.
    Wen J; Huang S; Pack SD; Yu X; Brandt SJ; Noguchi CT
    J Biol Chem; 2005 Apr; 280(13):12956-66. PubMed ID: 15677454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting dual oncogenic machineries driven by TAL1 and PI3K-AKT pathways in T-cell acute lymphoblastic leukemia.
    Lim FQ; Chan AS; Yokomori R; Huang XZ; Theardy MS; Yeoh AEJ; Tan SH; Sanda T
    Haematologica; 2023 Feb; 108(2):367-381. PubMed ID: 36073513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Helix-loop-helix (E2-5, HEB, TAL1 and Id1) protein interaction with the TCRalphadelta enhancers.
    Bernard M; Delabesse E; Smit L; Millien C; Kirsch IR; Strominger JL; Macintyre EA
    Int Immunol; 1998 Oct; 10(10):1539-49. PubMed ID: 9796921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-7 Functions as a Tumor Suppressor by Targeting the Oncogenes TAL1 in T-Cell Acute Lymphoblastic Leukemia.
    Sun H; Zhang Z; Luo W; Liu J; Lou Y; Xia S
    Technol Cancer Res Treat; 2020; 19():1533033820934130. PubMed ID: 32633635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular Mechanisms of ARID5B-Mediated Genetic Susceptibility to Acute Lymphoblastic Leukemia.
    Zhao X; Qian M; Goodings C; Zhang Y; Yang W; Wang P; Xu B; Tian C; Pui CH; Hunger SP; Raetz EA; Devidas M; Relling MV; Loh ML; Savic D; Li C; Yang JJ
    J Natl Cancer Inst; 2022 Sep; 114(9):1287-1295. PubMed ID: 35575404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p300 functions as a transcriptional coactivator for the TAL1/SCL oncoprotein.
    Huang S; Qiu Y; Stein RW; Brandt SJ
    Oncogene; 1999 Sep; 18(35):4958-67. PubMed ID: 10490830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamic interaction between TAL1 oncoprotein and LSD1 regulates TAL1 function in hematopoiesis and leukemogenesis.
    Li Y; Deng C; Hu X; Patel B; Fu X; Qiu Y; Brand M; Zhao K; Huang S
    Oncogene; 2012 Nov; 31(48):5007-18. PubMed ID: 22310283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SCL, LMO1 and Notch1 reprogram thymocytes into self-renewing cells.
    Gerby B; Tremblay CS; Tremblay M; Rojas-Sutterlin S; Herblot S; Hébert J; Sauvageau G; Lemieux S; Lécuyer E; Veiga DF; Hoang T
    PLoS Genet; 2014 Dec; 10(12):e1004768. PubMed ID: 25522233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MYCN is a novel oncogenic target in pediatric T-cell acute lymphoblastic leukemia.
    Astolfi A; Vendemini F; Urbini M; Melchionda F; Masetti R; Franzoni M; Libri V; Serravalle S; Togni M; Paone G; Montemurro L; Bressanin D; Chiarini F; Martelli AM; Tonelli R; Pession A
    Oncotarget; 2014 Jan; 5(1):120-30. PubMed ID: 24334727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erythropoietin stimulates transcription of the TAL1/SCL gene and phosphorylation of its protein products.
    Prasad KS; Jordan JE; Koury MJ; Bondurant MC; Brandt SJ
    J Biol Chem; 1995 May; 270(19):11603-11. PubMed ID: 7744799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discrimination between different E-box-binding proteins at an endogenous target gene of c-myc.
    Desbarats L; Gaubatz S; Eilers M
    Genes Dev; 1996 Feb; 10(4):447-60. PubMed ID: 8600028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.